Tag: Surgery
Research in Clonidine shows promise in the treatment of Sciatica
Sciatica also known as lumbosacral radiculopathy or radicular leg pain is a chronic pain condition that affects approximately 1 in 20 adults each year...
PhaseBio poised to make rapid strides in the Anti-Coagulant Reversal Market
PhaseBio’s (NASDAQ: PHAS), PB2452 is the new drug on the block, which has received a breakthrough therapy status from the FDA in April 2019....
TG Therapeutics – Spearheading Innovations in Lymphoma Treatment
TG Therapeutics (NASDAQ: TGTX), a clinical stage company that is leading the innovation bandwagon in the field of novel therapies for B-cell malignancies and autoimmune...
Can These Breakthrough Therapeutics win the fight against Mesothelioma?
An estimated 2,400 – 2,800 new incidence of Mesothelioma occurs each year in the U.S alone, according to an estimate by the Centers for...
We are looking for talented interns to learn and help investors find valuable companies.